Search
for

    Sort by

    Research 61–90 of 1000+

    1. Testosterone-stimulated weanlings as an alternative to castrated male rats in the Hershberger anti-androgen assay Regulatory Toxicology and Pharmacology · 2004 · 25 citations
    2. Testosterone therapy in men: Clinical and pharmacological perspectives Journal of Endocrinological Investigation · 2000 · 25 citations
    3. The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia Gynecological Endocrinology · 2011 · 15 citations
    4. The prevention of benign prostatic hyperplasia (bph) Medical Hypotheses · 2016 · 12 citations
    5. Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient Diabetes Therapy · 2022
    6. Pharmacological Effects of the Lipidosterolic Extract from Kigelia africana Fruits in Experimental Benign Prostatic Hyperplasia Induced by Testosterone in Sprague Dawley Rats Journal of Experimental Pharmacology · 2023 · 3 citations
    7. Phenyl Propanoid 1’s-1′-Acetoxychavicol Acetate Protects Against Testosterone-Induced Alopecia by Inhibiting Nadph Oxidase 2025
    8. A Natural Product Molecule of Artocarpus Heterophyllus Reverses Inflammation Due to the Effect of Acute Exposure of Prostate Tissue to Testosterone Enanthate in Wistar Rats Journal of Cancer Therapy and Research · 2024
    9. Re: Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men with Suppressed Testosterone Production: A Randomized Controlled Trial The Journal of Urology · 2012
    10. Control of testosterone 5alpha-reductase activity in the human hyperplastic prostate Enlighten: Theses (The University of Glasgow) · 1978
    11. Selective non-steroidal inhibitors of 5α-reductase type 1 2004 · 49 citations
    12. PERANCANGAN PROGRAM APLIKASI PENGENALAN SUARA PADA WINDOWS MENGGUNAKAN FOURIER METHOD Acta urologica Belgica · 2009
    13. 46,XY DSD due to impaired androgen production 2010 · 54 citations
    14. Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia Expert Opinion on Investigational Drugs · 1999 · 32 citations
    15. Steroidogenic enzymes in skin. PubMed · 2001 · 21 citations
    16. Finasteride 2004
    17. Antiandrogens CRC Press eBooks · 2022
    18. OR09-5 Importance of Islet Intracrinology for Glucose-Stimulated Insulin Secretion (GSIS) in the Male Journal of the Endocrine Society · 2019
    19. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Open MIND · 2026
    20. Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women Cureus · 2023
    21. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992 · 1040 citations
    22. Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat Toxicological Sciences · 2003 · 118 citations
    23. Finasteride: A slow-binding 5.alpha.-reductase inhibitor Biochemistry · 1993 · 70 citations
    24. Finasteride in the treatment of alopecia Expert Opinion on Pharmacotherapy · 2004 · 62 citations
    25. Finasteride for female androgenetic alopecia British Journal of Dermatology · 2002 · 51 citations
    26. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. PubMed · 2001 · 41 citations
    27. Sex dependent influence of a functional polymorphism in steroid 5‐α‐reductase type 2 (<i>SRD5A2</i>) on post‐traumatic stress symptoms American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2013 · 35 citations
    28. Minoxidil increases 17β-hydroxysteroid dehydrogenase and 5α-reductase activity of cultured human dermal papilla cells from balding scalp Journal of Dermatological Science · 1999 · 34 citations
    29. Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Therapeutics and Clinical Risk Management · 2009 · 33 citations
    30. Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes <i>In Vitro</i> Hormone and metabolic research · 2007 · 24 citations